Xenon Pharmaceuticals (XENE) Ownership - Who owns Xenon Pharmaceuticals?

Industry: @Biotechnology

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

200-3650 Gilmore Way

Phone

+1 604 484-3300

Employees

259

Web

https://www.xenon-pharma.com

Details

Group

Domestic Stock Funds

Fundamentals

XENE

Capitalization

2.92B

P/E Ratio

N/A

Risk (Beta)

1.16

Dividend Yield

N/A

Total Cash

722M

Total Cash/Share

9.52

Total Debt

10M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

844M

P/B Ratio

3.45

Cash Flow

N/A

Earnings

-2.73

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

1.44B

Current Ratio

23.27

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-233.68M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-25.38

Shares Held By Institutions

5.31B

Shares Outstanding - Current

75.8M

Total Liabilities

40M

Total Volume MTD

N/A

Value

-1

Gain YTD

-13.569

View a ticker or compare two or three

Compare

XENE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For XENE
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for XENE (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a provider of drug discovery and development services

Industry Biotechnology